TLR4-IN-C34 产品活性：TLR4-IN-C34 是具有口服活性的 TLR4 抑制剂，可改善内毒素血症和坏死性小肠结肠炎模型的全身炎症。 产品来源： https://www.medchemexpress.cn/tlr4-in-c34.html 研究领域：Immunology/Inflammation 作用靶点：Toll-like Receptor (TLR) In Vivo: TLR4-IN-C34 (C34, 1 mg/kg, orally daily) could attenuate NEC severity and demonstrates a marked preservation of the intestinal mucosa. 相关产品：Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Small Molecule Immuno-Oncology Compound Library | Antioxidant Compound Library | Differentiation Inducing Compound Library | Glycoside Compound Library | Oxygen Sensing Compound Library | Pyroptosis Compound Library | Anti-Obesity Compound Library | Targeted Diversity Library | Heterocyclic Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Autoimmune Disease Compound Library | Radioprotector Library | Bioactive Compound Library Max | Anti-Fibrosis Compound Library | Chloroquine | Lipopolysaccharides | Resatorvid | Resiquimod | Polyinosinic-polycytidylic acid | C29 | Imiquimod | Hydroxychloroquine | Pam3CSK4 TFA | Enpatoran | ODN 1826 | CU-CPT 4a | Complete Freund's adjuvant (CFA) | Sulfo-ara-F-NMN | Agatolimod | Diprovocim | Telratolimod | CU-CPT22 | Vesatolimod | Motolimod | Evolocumab | ODN 2216 | ABR-238901 | Pepinh-TRIF TFA | TH1020 | ODN 1018 | AT791 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。